NEW YORK, April 25 -Qiagen has lent its RNAi expertise to scientists on the front lines of SARS research, stepping in to contribute its RNA interference design resource, along with its custom siRNA and other sample preparation and nucleic acid chemistry products to laboratories in Hong Kong, China, Singapore, and Canada, the company said this week.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.